12 Key pharmacokinetic and pharmacodynamic parameters that correlate with the anti-tumor activity of a bispecific PD-L1 conditional 4–1BB agonist
Kinkead, Heather, Macedo, Chelsie, Sanabria, Angelica, Cyprus, Garrett, Pandit, Rajay, Kalabus, James, Becklund, Bryan, Sulzmaier, Florian, Timmer, John, Deveraux, Quinn, Eckelman, Brendan, Heidt, Analeah
Published in Journal for immunotherapy of cancer (01.11.2021)
Published in Journal for immunotherapy of cancer (01.11.2021)
Get full text
Journal Article
722 INBRX-121 is an NKp46-targeted detuned IL-2 with antitumor activity as a monotherapy or in combination with multiple cancer immunotherapy modalities
Sulzmaier, Florian, Kinkead, Heather, Polovina, Anya, Kern, Nadja, Sanabria, Angelica, Macedo, Chelsie, Hussain, Abrahim, Ahn, Sae Jeong, Pandit, Rajay, Crago, William, Timmer, John, Heidt, Analeah, Eckelman, Brendan
Published in Journal for immunotherapy of cancer (01.11.2021)
Published in Journal for immunotherapy of cancer (01.11.2021)
Get full text
Journal Article
Computed tomography findings of Crouzon syndrome: A case report
Neira, Juan Guillermo Arámbula, Herazo, Valeria del Castillo, Cuenca, Nury Tatiana Rincón, Sanabria Cano, Angélica M., Sarmiento, Maryi Fernanda Bermudez, Castro, María F., Ortiz, Andrés Felipe Herrera
Published in Radiology case reports (01.04.2022)
Published in Radiology case reports (01.04.2022)
Get full text
Journal Article
Drug-regulated CD33-targeted CAR T cells control AML using clinically optimized rapamycin dosing
Appelbaum, Jacob, Price, April E, Oda, Kaori, Zhang, Joy, Leung, Wai-Hang, Tampella, Giacomo, Xia, Dong, So, Pauline Pl, Hilton, Sarah K, Evandy, Claudya, Sarkar, Semanti, Martin, Unja, Krostag, Anne-Rachel, Leonardi, Marissa, Zak, Daniel E, Logan, Rachael, Lewis, Paula, Franke-Welch, Secil, Ngwenyama, Njabulo, Fitzgerald, Michael, Tulberg, Niklas, Rawlings-Rhea, Stephanie, Gardner, Rebecca A, Jones, Kyle, Sanabria, Angelica, Crago, William, Timmer, John, Hollands, Andrew, Eckelman, Brendan, Bilic, Sanela, Woodworth, Jim, Lamble, Adam, Gregory, Philip D, Jarjour, Jordan, Pogson, Mark, Gustafson, Joshua A, Astrakhan, Alexander, Jensen, Michael C
Published in The Journal of clinical investigation (01.05.2024)
Published in The Journal of clinical investigation (01.05.2024)
Get full text
Journal Article
Abstract 3513: INBRX-121, a safe and efficacious molecular targeted cytokine that enhances NK cell-mediated tumor killing
Kinkead, Heather, Sulzmaier, Florian J., Polovina, Anya, Kern, Nadja, Sanabria, Angelica, Ho, Jason, Macedo, Chelsie, Henderson, Ryan, Hussain, Abrahim, Pandit, Rajay, Crago, William, Rowell, Emily, Eckelman, Brendan P.
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Get full text
Journal Article
CLL-1 표적화 면역요법
TIMMER JOHN C, POGSON MARK, LEUNG WAI HANG, SANABRIA ANGELICA, ECKELMAN BRENDAN P, RASCON LUCAS, JARJOUR JORDAN
Year of Publication 11.03.2022
Get full text
Year of Publication 11.03.2022
Patent
CD33 결합 폴리펩타이드 및 이의 용도
GANO JACOB, TIMMER JOHN C, CRAGO WILLIAM, HOLLANDS ANDREW, JONES KYLE, SANABRIA ANGELICA, MA MILTON, ECKELMAN BRENDAN P
Year of Publication 11.01.2022
Get full text
Year of Publication 11.01.2022
Patent
CD33 표적화 면역요법
GANO JACOB, TIMMER JOHN C, POGSON MARK, CRAGO WILLIAM, HOLLANDS ANDREW, LEUNG WAI HANG, JONES KYLE, SANABRIA ANGELICA, MA MILTON, ECKELMAN BRENDAN P, JARJOUR JORDAN
Year of Publication 11.03.2022
Get full text
Year of Publication 11.03.2022
Patent
CLEC12a binding polypeptides and uses thereof
Timmer, John C, Rascon, Lucas, Eckelman, Brendan P, Sanabria, Angelica
Year of Publication 23.07.2024
Get full text
Year of Publication 23.07.2024
Patent
PD-1 single domain antibodies and therapeutic compositions thereof
Timmer, John C, Eckelman, Brendan P, Sulzmaier, Florian, Pandit, Rajay A, Sanabria, Angelica N
Year of Publication 02.04.2024
Get full text
Year of Publication 02.04.2024
Patent
CLEC12A-BINDING POLYPEPTIDES AND USES THEREOF
RASCON, Lucas, TIMMER, John C, SANABRIA, Angelica, ECKELMAN, Brendan P
Year of Publication 16.03.2022
Get full text
Year of Publication 16.03.2022
Patent
CD33-binding polypeptides and uses thereof
Timmer, John C, Eckelman, Brendan P, Jones, Kyle S, Ma, Milton, Sanabria, Angelica, Gano, Jacob, Crago, William, Hollands, Andrew
Year of Publication 10.09.2024
Get full text
Year of Publication 10.09.2024
Patent
CLEC12A-BINDING POLYPEPTIDES AND USES THEREOF
RASCON, Lucas, TIMMER, John C, SANABRIA, Angelica, ECKELMAN, Brendan P
Year of Publication 29.11.2021
Get full text
Year of Publication 29.11.2021
Patent
CLEC12a-binding polypeptides and uses thereof
RASCON, Lucas, TIMMER, John C, SANABRIA, Angelica, ECKELMAN, Brendan P
Year of Publication 11.11.2021
Get full text
Year of Publication 11.11.2021
Patent
PD-1 SINGLE DOMAIN ANTIBODIES AND THERAPEUTIC COMPOSITIONS THEREOF
SULZMAIER, Florian, PANDIT, Rajay, TIMMER, John, ECKELMAN, Brendan, SANABRIA, Angelica
Year of Publication 18.08.2021
Get full text
Year of Publication 18.08.2021
Patent
PD-1 single domain antibodies and therapeutic compositions thereof
SULZMAIER, Florian, PANDIT, Rajay, TIMMER, John, ECKELMAN, Brendan, SANABRIA, Angelica
Year of Publication 27.05.2021
Get full text
Year of Publication 27.05.2021
Patent
CD33-Binding Polypeptides and Uses Thereof
Timmer, John C, Eckelman, Brendan P, Jones, Kyle S, Ma, Milton, Sanabria, Angelica, Gano, Jacob, Crago, William, Hollands, Andrew
Year of Publication 05.10.2023
Get full text
Year of Publication 05.10.2023
Patent
CLEC12A-BINDING POLYPEPTIDES AND USES THEREOF
SANABRIA, ANGELICA, TIMMER, JOHN C, ECKELMAN, BRENDAN P, RASCON, LUCAS
Year of Publication 12.11.2020
Get full text
Year of Publication 12.11.2020
Patent
CLEC12A-BINDING POLYPEPTIDES AND USES THEREOF
RASCON, Lucas, TIMMER, John C, SANABRIA, Angelica, ECKELMAN, Brendan P
Year of Publication 12.11.2020
Get full text
Year of Publication 12.11.2020
Patent